Glucose Homeostasis in Mice Is Transglutaminase 2 Independent

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Iismaa, Siiri E ^a,c   Aplin, Mark ^a   Holman, Sara ^a   Yiu, Ting W ^a,c   Jackson, Kristy ^a   Burchfield, James G ^b   Mitchell, Christopher J ^b   O'Reilly, Liam ^b   Davenport, Aimee ^b   Cantley, James ^b   Schmitz Peiffer, Carsten ^b   Biden, Trevor J ^b   Cooney, Gregory J ^b   Graham, Robert M ^a,c  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TOLERANCE TEST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; GENE DELETION; GENOTYPE; GLUCOSE; GLUCOSE TOLERANCE TEST; GTP-BINDING PROTEINS; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSGLUTAMINASES;

EID: 84878067137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063346     Document Type: Article

References (39)

1. Ledermann HM, (1995) Maturity-onset diabetes of the young (MODY) at least ten times more commin in Europe than previously assumed? Diabetologia 38: 1482.
2. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, et al. (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53: 2504-2508.
3. Bernassola F, Federici M, Corazzari M, Terrinoni A, Hribal ML, et al. (2002) Role of transglutaminase 2 in glucose tolerance: knockout mice studies and putative mutation in a MODY patient. FASEB J 16: 1371-1378.
4. Porzio O, Massa O, Cunsolo V, Colombo C, Malaponti M, et al. (2007) Missense mutations in the TGM2 gene encoding Transglutaminase 2 are found in patients with early-onset Type 2 diabetes. Hum Mutat 28: 1150.
5. De Laurenzi V, Melino G, (2001) Gene disruption of tissue transglutaminase. Mol Cell Biol 21: 148-155.
6. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, et al. (2001) Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276: 20673-20678.
7. Iismaa SE, Mearns BM, Lorand L, Graham RM, (2009) Transglutaminases and disease: Lessons from genetically-engineered mosue models and inherited disorders. Physiol Rev 89: 991-1023.
8. Lorand L, Graham RM, (2003) Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4: 140-157.
9. Achyuthan KE, Greenberg CS, (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262: 1901-1906.
10. Im M-J, Riek RP, Graham RM, (1990) A novel guanine nucleotide-binding protein coupled to the α1-adrenergic receptor. II. Purification, characterization, and reconstitution. J Biol Chem 265: 18952-18960.
11. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, et al. (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264: 1593-1596.
12. Chen SH, Lin F, Iismaa S, Lee KN, Birckbichler PJ, et al. (1996) α1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem 271: 32385-32391.
13. Dupuis M, Levy A, Mhaouty-Kodja S, (2004) Functional coupling of rat myometrial alpha 1-adrenergic receptors to Gh alpha/tissue transglutaminase 2 during pregnancy. J Biol Chem 279: 19257-19263.
14. Vezza R, Habib A, FitzGerald GA, (1999) Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J Biol Chem 274: 12774-12779.
15. Zhang Z, Vezza R, Plappert T, McNamara P, Lawson JA, et al. (2003) COX-2 dependent cardiac failure in Gh/tTG transgenic mice. Circ Res 92: 1153-1161.
16. Park ES, Won JH, Han KJ, Suh PG, Ryu SH, et al. (1998) Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector. Biochem J 331: 283-289.
17. Akimov SS, Krylov D, Fleischmann LF, Belkin AM, (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148: 825-838.
18. Bungay PJ, Potter JM, Griffin M, (1984) The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. Biochem J 219: 819-827.
19. Paulmann N, Grohmann M, Voigt J-P, Bert B, Vowinckel J, et al. (2009) Intracellular serotonin modulates insulin secretion from pancreatic β-cells by protein serotonylation. PLoS Biol 7: e1000229.
20. Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ, (1983) Transglutaminase activity in pancreatic islets. Biochim Biophys Acta 760: 384-388.
21. Salter NW, Ande SR, Nyguyen HK, Nyomba BLG, Mishra S, (2012) Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes. Journal of Molecular Endocrinology 48: 203-216.
22. Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, et al. (2000) Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49: 392-398.
23. Gilon P, Henquin J-C, (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22: 565-604.
24. Duttaroy A, Zimliki CL, Gautam D, Cui Y, Mears D, et al. (2004) Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in M3 muscarinic acetylcholine receptor-deficient mice. Diabetes 53: 1714-1720.
25. Schmitz-Peiffer C, Laybutt DR, Burchfield JG, Gurisik E, Narasimhan S, et al. (2007) Inhibition of PKCε improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 6: 320-328.
26. Cantley J, Boslem E, Laybutt DR, Cordery DV, Pearson G, et al. (2011) Deletion of protein kinase Cδ in mice modulates stability of inflammatory genes and protects against cytokine-stimulated beta cell death in vitro and in vivo. Diabetologia 54: 380-389.
27. Carpenter L, Mitchell CJ, Xu ZZ, Poronnik P, Both GW, et al. (2004) PKCα is activated but not required during glucose-induced insulin secretion from rat pancreatic islets. Diabetes 53: 53-60.
28. Iismaa SE, Wu M-J, Nanda N, Church WB, Graham RM, (2000) GTP-binding and signalling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem 275: 18259-18265.
29. Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, et al. (2006) Mutation of a critical GTP-binding arginine in transglutaminase 2 disinhibits intracellular crosslinking activity. J Biol Chem 281: 12603-12609.
30. Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE, (1995) Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11: 206-211.
31. Andrikopoulos S, Massa CM, Aston-Mourney KA, Funkat A, Fam BC, et al. (2005) Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol 187: 45-53.
32. Goren HJ, Kulkarni RN, Kahn CR, (2004) Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strins of mice: C57BL/6, C57BLKS/6, DBA/2 and 129X1. Endocrinology 145: 3307-3323.
33. Leiter EH, (2002) Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 45: 296-308.
34. Brennan K (2011) Colony Management. In: Pease S, Saunders TL, editors. Advanced protocols for animal transgenesis An ISTT manual. 1st ed. Berlin: Springer-Verlag. 535-576.
35. Wong GT, (2002) Speed congenics: Applications for transgenic and knock-out mouse strains. Neuropeptides 36: 230-236.
36. Lorand L, Conrad SM, (1984) Transglutaminases. Mol Cell Biochem 58: 9-35.
37. Calkins MJ, Townsend JA, Johnson DA, Johnson JA, (2010) Cystamine protects form 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Experimental Neurology 224: 307-317.
38. Ruan Q, Johnson GVW, (2007) Transglutaminase 2 in neurodegenerative disorders. Front Biosci 12: 891-904.
39. Davies PJA, Cornwell MM, Johnson JD, Reggianni A, Myers M, et al. (1984) Studies on the effects of dansylcadaverine and related compounds on receptor-mediated endocytosis in cultured cells. Diabetes Care 7(Suppl 1): 35-41.